U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753226) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors' on Aug. 04.
Brief Summary: This study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advanced or metastatic breast cancer and other solid tumors.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Solid Tumor
Intervention:
DRUG: SI-B036
Administration by intravenous infusion for a cycl...